Pulmonary Hypertension in Heart Failure Patients-Reference-Cited by-同舟云学术

Pulmonary Hypertension in Heart Failure Patients

Published:2020-04-09 Issue: Volume:6 Page:
ISSN:2057-7559
Container-title:Cardiac Failure Review
language:en
Short-container-title:Card Fail Rev

Author:

Rao Sriram D¹,Adusumalli Srinath²,Mazurek Jeremy A³

Affiliation:

1. Advanced Heart Failure/Transplantation Programme, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, US

2. Department of Medicine, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, US

3. Advanced Heart Failure/Transplantation Programme, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, US; Pulmonary Hypertension Programme, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, US

Abstract

The development of pulmonary hypertension (PH) in patients with heart failure is associated with increased morbidity and mortality. In this article, the authors examine recent changes to the definition of PH in the setting of left heart disease (PH-LHD), and discuss its epidemiology, pathophysiology and prognosis. They also explore the complexities of diagnosing PH-LHD and the current evidence for the use of medical therapies, promising clinical trials and the role of left ventricular assist device and transplantation.

Publisher

Radcliffe Group Ltd

Subject

Cardiology and Cardiovascular Medicine

Reference67 articles.

1. Guazzi M, Borlaug B. Pulmonary hypertension due to left heart disease. Circulation 2012;126:975–90. https://doi.org/10.1161/CIRCULATIONAHA.111.085761; PMID: 22908015.

2. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Heart J 2016;37:67–119. https://doi.org/10.1093/eurheartj/ehv317; PMID: 26320113.

3. Rosenkranz S, Gibbs JSR, Wachter R, et al. Left ventricular heart failure and pulmonary hypertension. Eur Heart J 2016;37:942–54. https://doi.org/10.1093/eurheartj/ehv512; PMID: 26508169.

4. Vachiéry JL, Tedford RJ, Rosenkranz S, et al. Pulmonary hypertension due to left heart disease. Eur Respir J 2018;53:pii:1801897 https://doi.org/10.1183/13993003.01897-2018; PMID: 30545974.

5. Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019;53:1801913. https://doi.org/10.1183/13993003.01913-2018; PMID: 30545968.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Point of Care Ultrasound (POCUS) in the Management of Heart Failure: A Narrative Review;Journal of Personalized Medicine;2024-07-18

2. The role of serum sodium in poor prognosis evaluation of pulmonary hypertension associated with left heart disease;The American Journal of the Medical Sciences;2024-06

3. Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction;Journal of the American College of Cardiology;2024-02

4. An Unusual Presentation of Co-existence of Leprosy, Anetoderma and Abdominal Tuberculosis: A Case Report;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024

5. Cine MRI-derived radiomics features indicate hemodynamic changes in the pulmonary artery;The International Journal of Cardiovascular Imaging;2023-11-16